Organization
Akdeniz University
1 clinical trial
3 abstracts
Abstract
ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).Org: Sarah Cannon Research Institute/Tennessee Oncology, Jilin Cancer Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Federal State Budgetary Institution “N. N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Beijing Cancer Hospital,
Clinical trial
The Impact of Estrogen Administration Duration on Live Birth Rates in Hormonally Prepared Frozen Embryo Transfer Cycles: A Prospective Controlled StudyStatus: Completed, Estimated PCD: 2021-12-31
Abstract
A NEW TNFRSF1A GENE MUTATION IN A TURKISH FAMILY WITH TNF RECEPTOR-ASSOCIATED PERIODIC SYNDROME (TRAPS).Org: Akdeniz University, Rheumatology Clinic, East Lansing, Antalya, Turkey,
Abstract
Biologic Drug Preferences of Turkish Rheumatologists in Spondiloartropathy Patients with Advanced Chronic Renal DiseaseOrg: Namik Kemal University, Kartal Lütfi Kirdar City Hospital, Uludağ University Hospital, Ankara University, Yildirim Beyazit University,